ELECTROCONVULSIVE THERAPY AS A LAST RESORT IN TREATING SEVERE DEPRESSION AND BIPOLAR DISORDER
Abstract
Treatment of bipolar depression (BD-D) continues to represent a significant unmet need. On average, patients with bipolar disorder (both bipolar I (BD-I), defined by the presence of mania, and bipolar II (BD-II), defined by presence of hypomania) who are treated according to established guidelines are euthymic only about 50% of the time. Further, patients with bipolar disorder spend three times more days depressed than manic or hypomanic. Depression, therefore, represents a quite common mood state among patients with bipolar disorder. This is particularly worrisome as BD-D significantly impacts an individual’s psychosocial functioning, with impairments in work, social and family life. Suicides, which are disproportionately high in bipolar disorder, predominantly occur in the depressive state. Furthermore, BD-D is the major contributor to disability associated with the illness. Despite these serious adverse impacts of bipolar disorder, over 50% of patients with bipolar disorder are at least partially non-adherent to medications. Many factors contribute to non-adherence, including lack of psychoeducation and insight into the chronic and episodic nature of the disease.Additionally, a significant number of patients experience intolerable side effects of medications.
Keywords
Treatment, DepressionHow to Cite
References
Altshuler, L.L., et al., Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry, 2006. 67(10): p. 1551-60.
Baastrup, P.C. and M. Schou, Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry, 1967. 16(2): p. 162-72.
Basso, M.R., et al., Neuropsychological impairment among manic, depressed, and mixed-episode inpatients with bipolar disorder. Neuropsychology, 2002. 16(1): p. 84-91.
Calabrese, J.R., et al., A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry, 2005. 162(7): p. 1351-60.
Connolly, K.R. and M.E. Thase, The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord, 2011. 13(4).
Frank, E., et al., Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry, 2005. 62(9): p. 996-1004.
Hsiao, Y.L., et al., Neuropsychological functions in patients with bipolar I and bipolar II disorder. Bipolar Disord, 2009. 11(5): p. 547-54.
Jaeger, J., et al., Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord, 2007. 9(1-2): p. 93-102.
Malhi, G.S., D. Adams, and M. Berk, Medicating mood with maintenance in mind: bipolar depression pharmacotherapy. Bipolar Disord, 2009. 11 Suppl 2: p. 55-76.
Perlis, R.H., et al., Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry, 2006. 163(2): p. 217-24.
Pini, S., et al., Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol, 2005. 15(4): p. 425-34.
Post, R.M., et al., Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry, 2003. 64(6): p. 680-90; quiz 738-9.
Quraishi, S. and S. Frangou, Neuropsychology of bipolar disorder: a review. J Affect Disord, 2002. 72(3): p. 209-26.
Reinares, M., et al., A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. Int J Neuropsychopharmacol, 2013. 16(2): p. 485-96.
Robinson, L.J. and I.N. Ferrier, Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord, 2006. 8(2): p. 103-16.
Thase, M.E., The role of monoamine oxidase inhibitors in depression treatment guidelines. J Clin Psychiatry, 2012. 73 Suppl 1: p. 10-6.
License
Copyright (c) 2021 JYOTI SISODIYA
This work is licensed under a Creative Commons Attribution 4.0 International License.
Individual articles are published Open Access under the Creative Commons Licence: CC-BY 4.0.
